阿托伐他汀对冠状动脉支架预后的影响  

Effects of atorvastatin on prognosis in the treatment of percutaneous coronary intervention

作　　者：魏静霞[1] 牛新丽[1] 路世红[1] 

机构地区：[1]河南省新乡市第一人民医院心内科,新乡453000

出　　处：《中原医刊》2007年第4期31-32,共2页Central Plains Medical Journal

摘　　要：目的 研究阿托伐他汀对冠状动脉支架后的临床影响。方法 76例接受PTCA＋Stenting（PCI）的患者分成阿托伐他汀干预治疗组（A组）和普通治疗组（B组），观察PCI后两组患者心绞痛的发作情况及超声心动图EF值的变化，随访6个月。结果 A组的心绞痛发生率较B组明显减低（P〈0．01），心肌梗死发生率A组低于B组（P〈0．05），EF值A组较B组明显改善（P〈0．01）。结论 阿托伐他汀对冠状动脉支架后的心绞痛缓解、心肌梗死的预防及心功能的恢复均有较好效果。Objective To investigate the clinical influence of atorvastatin on patients received in the treatment of percutaneous coronany intervention （PCI）. Methods 76 patients received PCI treatment were divided into two groups randomly：atorvastatin group（group A） and control group（group B）,The attack of cardiac angina and the change of ejection fraetion （EF） were observed after PCI in two groups followed - up six months. Results The incidence of cardiac angina of group A was lower than that of group B （ P 〈0.01 ） ; The incidence of acute myocardial infarction of group A was lower than that of group B too （ P 〈 0.05 ） ; EF in group A was greatly superior to that in group B （ P 〈 0. 01 ）. Conclusion Atorvastatin is effective to patients after received PCI treatment in relieving the occurrenc of cardiac angina and myicardial infarction, and advancing the cardiac function of patients.

关 键 词：阿托伐他汀 冠状动脉支架 预后 

分 类 号：R541[医药卫生—心血管疾病]